Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/biomedical-advances-in-hiv-prevention/descriptif_2853680
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=2853680

Biomedical Advances in HIV Prevention, Softcover reprint of the original 1st ed. 2014 Social and Behavioral Perspectives

Langue : Anglais

Coordonnateurs : Eaton Lisa A., Kalichman Seth C.

Couverture de l’ouvrage Biomedical Advances in HIV Prevention

Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives

Lisa A. Eaton and Seth C. Kalichman, editors

Three decades into the epidemic, a great deal is known about HIV and its transmission, more people are living with the disease, and the virus is no longer seen as a death sentence. But new people continue to be infected with HIV each year, making prevention strategies that are medically effective and behaviorally engaging as urgent a priority as ever.

Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives assembles the latest improvements, barriers to implementation, and possibilities for--and challengesto--future progress. Innovations such as pre-exposure prophylaxis (antiretroviral regimens for the high-risk uninfected) and treatment as prevention (early use of ART to reduce infectiousness of new patients) are examined, as are current findings on ongoing prevention and treatment concerns.

Contributors illuminate the complex realities entailing adherence, pointing out technological, behavioral, and cultural roadblocks as well as opportunities to significantly reduce infection rates. Detailed up-to-the-minute coverage includes:

  • Prevention services for persons living with HIV
  • Adherence to HIV treatment as prevention and pre-exposure prophylaxis
  • Advocating for rectal microbicides and safe lubricants
  • Mental health and substance use in the scale-up of HIV prevention
  • Risk compensation in response to HIV prevention
  • Implementing biomedical HIV prevention advances: reports from South Africa, Uganda, Australia, Thailand, United States, Ecuador, and Peru

Researchers, practitioners, and policy makers working in the fields of HIV/AIDS and public health will look toward BiomedicalAdvancesinHIVPrevention: Social and Behavioral Perspectives as both a means for developing and assessing current programs and a blueprint for the next generation of prevention efforts.

Part I. Advances in HIV Prevention Technologies.- Chapter 1: Advances, Promises, and Challenges in HIV Prevention.- Chapter 2: Pre-Exposure Prophylaxis.- Chapter 3: Prevention Services with Persons Living with HIV.- Chapter 4: Advocating for Rectal Microbicides and Safe Lubricants.- Part II. Behavioral Challenges and Opportunities.- Chapter 5: Adherence to HIV Treatment as Prevention and Pre-Exposure Prophylaxis.- Chapter 6: Risk Compensation in Response to HIV Prevention.- Chapter 7: Mental Health and Substance Use in the Scale Up of HIV Prevention.- Chapter 8: Substance Use Treatment in the Era of New HIV Prevention Technologies.- Part III. Global Perspectives.-Chapter 9: Revolution or evolution? What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high-income countries?.- Chapter 10: Implementing Biomedical HIV Prevention Advances in Uganda.- Chapter 11: Implementing Biomedical HIV Prevention Advances in Thailand.- Chapter 12: Implementing Biomedical HIV Prevention Advances in Ecuador and Peru.

Seth C. Kalichman received his Ph.D. in Clinical-Community Psychology from the University of South Carolina in 1990. He has served on the faculties of Loyola University of Chicago, Georgia State University, and the Medical College of Wisconsin. He is currently a Professor in the Psychology Department at the University of Connecticut. He is the Director of the Social Processes of AIDS graduate training program. Dr. Kalichman has conducted AIDS prevention and treatment research since 1990 and his research has been continuously funded by the National Institutes of Health since 1994. He has published over 300 articles in peer-reviewed scientific journals, edited two books on AIDS. He dedicates his time to conducting HIV/AIDS behavioral research, focusing on developing and testing behavioral interventions to prevent the spread of HIV and minimize the adverse effects of HIV infection. He is the Director of the Southeast HIV-AIDS Research and Evaluation (SHARE) Project, community-based collaborative research group in Atlanta, Georgia and Cape Town, South Africa. He was the 1997 recipient of the Distinguished Scientific Award for Early Career Contribution to Psychology in Health, awarded by the American Psychological Association and the 2005 Distinguished Scientist Award from the Society for Behavioral Medicine. He is the Editor-in-chief of the peer-reviewed scientific journal AIDS and Behavior and the author of five books, including Denying AIDS: Conspiracy Theories, Pseudoscience, and Human Tragedy.

Only available book focusing in the rise in importance of behavioral research in the field of HIV / AIDS prevention

Of interest to public health researchers in both biomedicine who need to understand what behavioral intervention work with specific populations

Provides professional insight into the major paradigm shift occurring in the field of HIV prevention

Includes supplementary material: sn.pub/extras

Date de parution :

Ouvrage de 269 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 158,24 €

Ajouter au panier

Date de parution :

Ouvrage de 269 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 158,24 €

Ajouter au panier